Intuitive Surgical (ISRG) Tops Q2 EPS by 26c
Intuitive Surgical (NASDAQ: ISRG) reported Q2 EPS of $2.19, $0.26 better than the analyst estimate of $1.93. Revenue for the quarter came in at $2.44 billion versus the consensus estimate of $2.35 billion.
2025 Financial Outlook
The Company expects the following results for the full year of 2025:
•Worldwide da Vinci procedure growth of approximately 15.5% to 17% in 2025, compared to 17% in 2024.
•Non-GAAP* gross profit margin to be within a range of 66% and 67% of revenue in 2025, compared to 69.1% in 2024. This range includes an estimated impact from tariffs of 1.0% of revenue, plus or minus 20 basis points.
•Non-GAAP* operating expense growth of 10% to 14% in 2025, compared to 10% in 2024
For earnings history and earnings-related data on Intuitive Surgical (ISRG) click here.